TY - JOUR
T1 - Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone ct and mri in the management of head and neck cancer patients
AU - Subramaniam, Rathan M.
AU - Agarwal, Ankit
AU - Colucci, Andrew
AU - Ferraro, Regan
AU - Paidpally, Vasavi
AU - Mercier, Gustavo
PY - 2013/10
Y1 - 2013/10
N2 - Purpose of the Report: This study aims to determine if the expansion of a PET/CT service to include simultaneous contrast-enhanced CT with PET (PET/DCT) leads to a reduction of supplemental diagnostic CT (sCT) performed within a 6-month period centered around PET/CT for initial treatment planning of patients with head and neck cancers. Patients and Methods: There were 91 patients with head and neck cancers who had a nonYcontrast-enhanced PET/CT with CT (PET/aCT), and 153 patients had a PET/DCT. We compared the utilization of sCT before and after PET/aCT or PET/DCT. Logistic regression analysis, unpaired t test, and analysis of variance were performed. Results: Among the 75 patients who had sCT scans in the 3 months before their PET/CT, 44 (58.7%) scans were performed in patients who had a PET/aCT and 31 (41.3%) scans were performed in patients who had a PET/DCT (P < 0.001). Among the 36 patients who had a CT in the 3 months after their baseline PET/CT, 23 (63.9%) were performed in patients who had a baseline PET/aCT and 13 (36.1%) were performed in patients who had a baseline PET/DCT (P < 0.001). The adjusted odds ratio for performing an sCT within 3 months before and after baseline PET/DCT scan as opposed to a PET/aCT scan was 0.24 (P < 0.001) and 0.31 (P G 0.01), respectively. Conclusions: The opportunity to order simultaneous diagnostic CT imaging with PET/CT (PET/DCT) reduced the referrals for stand-alone CT neck imaging in the initial treatment plan of head and neck cancer patients when compared to a service that only offered the PET/CT scan with CT for attenuation correction (PET/aCT).
AB - Purpose of the Report: This study aims to determine if the expansion of a PET/CT service to include simultaneous contrast-enhanced CT with PET (PET/DCT) leads to a reduction of supplemental diagnostic CT (sCT) performed within a 6-month period centered around PET/CT for initial treatment planning of patients with head and neck cancers. Patients and Methods: There were 91 patients with head and neck cancers who had a nonYcontrast-enhanced PET/CT with CT (PET/aCT), and 153 patients had a PET/DCT. We compared the utilization of sCT before and after PET/aCT or PET/DCT. Logistic regression analysis, unpaired t test, and analysis of variance were performed. Results: Among the 75 patients who had sCT scans in the 3 months before their PET/CT, 44 (58.7%) scans were performed in patients who had a PET/aCT and 31 (41.3%) scans were performed in patients who had a PET/DCT (P < 0.001). Among the 36 patients who had a CT in the 3 months after their baseline PET/CT, 23 (63.9%) were performed in patients who had a baseline PET/aCT and 13 (36.1%) were performed in patients who had a baseline PET/DCT (P < 0.001). The adjusted odds ratio for performing an sCT within 3 months before and after baseline PET/DCT scan as opposed to a PET/aCT scan was 0.24 (P < 0.001) and 0.31 (P G 0.01), respectively. Conclusions: The opportunity to order simultaneous diagnostic CT imaging with PET/CT (PET/DCT) reduced the referrals for stand-alone CT neck imaging in the initial treatment plan of head and neck cancer patients when compared to a service that only offered the PET/CT scan with CT for attenuation correction (PET/aCT).
KW - Contrast
KW - Contrast-enhanced PET/CT
KW - Referral pattern
UR - http://www.scopus.com/inward/record.url?scp=84897640697&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84897640697&partnerID=8YFLogxK
U2 - 10.1097/RLU.0b013e31829f8ca5
DO - 10.1097/RLU.0b013e31829f8ca5
M3 - Article
C2 - 23917783
AN - SCOPUS:84897640697
SN - 0363-9762
VL - 38
SP - 790
EP - 794
JO - Clinical nuclear medicine
JF - Clinical nuclear medicine
IS - 10
ER -